Skip to content

Clinical trials

Hepatitis B trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Country / region: South Korea Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20034
20041
20051
20061
20072
20081
20104
20111
20125
20142
20158
20163
20173
20188
20193
20205
20217
20223
20233
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Terminated16
Unknown status6
Active, not recruiting3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline10
Bukwang Pharmaceutical8
Vir Biotechnology, Inc.5
Arrowhead Pharmaceuticals4
Green Cross Corporation4
Dong-A ST Co., Ltd.3
Gilead Sciences3
Assembly Biosciences2
Bristol-Myers Squibb2
LG Chem2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B71
Hepatitis B, Chronic27
Hepatitis14
Hepatitis, Chronic6
Diphtheria3
Haemophilus Infections3
Liver Diseases3
Poliomyelitis3
Tetanus3
Whooping Cough3

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.